Oncimmune secures strategic commercialisation agreement in the US with Biodesix
LONDON: Oncimmune Holdings plc, a leading global immunodiagnostics group, has entered into an exclusive partnership agreement, which the Board believes will unlock the full potential of EarlyCDT Lung in the…